moxifloxacin has been researched along with fosaprepitant in 2 studies
| Studies (moxifloxacin) | Trials (moxifloxacin) | Recent Studies (post-2010) (moxifloxacin) | Studies (fosaprepitant) | Trials (fosaprepitant) | Recent Studies (post-2010) (fosaprepitant) |
|---|---|---|---|---|---|
| 3,157 | 552 | 1,690 | 120 | 44 | 104 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Constanzer, ML; Dru, J; Evans, JK; Han, TH; Jin, B; Marbury, TC; Murphy, MG; Panebianco, D; Shadle, CR; Sun, H | 1 |
1 review(s) available for moxifloxacin and fosaprepitant
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for moxifloxacin and fosaprepitant
| Article | Year |
|---|---|
Lack of effect of aprepitant or its prodrug fosaprepitant on QTc intervals in healthy subjects.
Topics: Adolescent; Adult; Anti-Infective Agents; Antidepressive Agents; Aprepitant; Aza Compounds; Cross-Over Studies; Double-Blind Method; Electrocardiography; Electrocardiography, Ambulatory; Female; Fluoroquinolones; Heart Rate; Humans; Linear Models; Male; Middle Aged; Morpholines; Moxifloxacin; Prodrugs; Quinolines; Young Adult | 2009 |